Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2005; 11(24): 3655-3659
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3655
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3655
Concentration (mmol/L) | Inhibition rate% | ||
24 h | 48 h | 72 h | |
0.52 | 2.37±0.45 | 3.88±1.05 | 13.43±2.46 |
0.74 | 5.51±0.63 | 10.11±1.89 | 30.05±2.44 |
1.06 | 14.50±3.12 | 30.84±4.77 | 53.25±4.65 |
1.51 | 32.71±4.23 | 58.49±6.24 | 71.88±3.91 |
2.16 | 55.73±4.38 | 78.56±7.18 | 86.57±4.42 |
3.08 | 70.44±7.38 | 91.67±5.38 | 94.89±3.80 |
4.40 | 81.83±5.08 | 97.80±2.52 | 99.07±0.29 |
6.29 | 89.53±5.71 | 97.67±1.94 | 98.54±0.96 |
IC50 | 2.30±0.26 | 1.41±0.15 | 1.02±0.05 |
- Citation: Liu W, Guo QL, You QD, Zhao L, Gu HY, Yuan ST. Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol 2005; 11(24): 3655-3659
- URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3655.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i24.3655